Solid Tumor Targeted Cancer Gene Panel by Next Generation Sequencing
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Identifying solid tumors that may respond to targeted therapies by assessing multiple gene targets simultaneously
Identifying specific mutations within genes known to be associated with response or resistance to specific cancer therapies
Identifying mutations that may help determine prognosis for patients with solid tumors
Assisting in establishing a diagnosis (eg, KIT and PDGFRA alterations for gastrointestinal stromal tumors)
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
This test uses targeted next-generation sequencing to evaluate for somatic mutations within 50 genes associated with cancer. See Targeted Gene Regions Interrogated by Solid Tumor Targeted Cancer Gene Panel by Next Generation Sequencing in Special Instructions for details regarding the targeted gene regions identified by this test.
Of note, this test is performed to evaluate for somatic mutations within solid tumor samples. This test is not intended for use for hematological malignancies. Additionally, this test does not assess for germline alterations within the genes listed.
Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)
|Test ID||Reporting Name||Available Separately||Always Performed|
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
When this test is ordered, slide review will always be performed at an additional charge.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
PCR-Based Next Generation Sequencing
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Solid Tumor Targeted Cancer Panel